Lenalidomide Capsules (Qipuyi®) – 25?mg × 21 Capsules per Box
1 × $1.00 
Atorvastatin Calcium Tablets (Baolong Pharma) 20mg – Low price wholesale comparison
1 × $3.00 Subtotal: $4.00
$2.00
Renhe Entecavir Tablets contain 0.5?mg entecavir per tablet in two blisters totaling 28 tablets per bottle. Manufactured by Jiangxi Pharmaceutical Co., Ltd., approved under NMPA H20213196. Designed for preclinical research in antiviral therapy against chronic hepatitis B.
?? For laboratory and research use only.?Please consult staff for other specifications and uses?
Entecavir is a potent nucleoside reverse transcriptase inhibitor (NRTI) effective against hepatitis B virus (HBV). These tablets are suitable for pharmacological and virology research involving antiviral efficacy, resistance mechanisms, and pharmacokinetics in hepatocyte models. The 0.5?mg strength aligns with standard dosing in chronic HBV studies.
| Parameter | Details |
|---|---|
| Product Name | Entecavir Tablets (Renhe) |
| Generic Name | Entecavir |
| CAS Number | 142217?69?4 |
| Molecular Formula | C??H??N?O? |
| Molecular Weight | ~277.28?g/mol |
| Dosage Form | Oral tablet |
| Strength | 0.5?mg per tablet |
| Pack Size | 14 tablets ×?2 blisters = 28 tablets per bottle |
| NMPA Approval No. | H20213196 |
| Drug Standard Code | 86905388003431 |
| Manufacturer | Jiangxi Pharmaceutical Co., Ltd. |
| Barcode | 6903919183458 |
| Storage Conditions | Store <?25?°C, sealed, protect from moisture and light |
| Intended Use | For laboratory and preclinical HBV antiviral research |
Entecavir acts as a guanosine analogue that inhibits HBV reverse transcriptase, preventing viral DNA synthesis in infected cells. It offers high antiviral potency with minimal resistance, making it a valuable compound in chronic HBV research.
Chronic hepatitis B viral suppression studies
Antiviral resistance and mutation modeling
Pharmacokinetic and bioavailability analysis
Combination therapy with other antivirals (e.g. tenofovir, lamivudine)
In vitro hepatocyte and in vivo animal studies
Handling: Use standard lab PPE—gloves, coat, goggles; avoid ingestion.
Storage: Maintain below 25?°C, sealed and dry.
Precautions: Designed for laboratory use only; not for human or veterinary administration.
entecavir tablets, entecavir 0.5mg, CAS 142217-69-4, H20213196, HBV research tablet, NRTI antiviral research, Renhe entecavir, wholesale entecavir
This product is for laboratory and preclinical research use only. It is not approved for clinical, therapeutic, diagnostic, or veterinary applications. Misuse may carry legal or health risks. Use under approved institutional protocols.
| 重量 | 1 公斤 |
|---|---|
| 尺寸 | 36 × 26 × 36 厘米 |
Select at least 2 products
to compare
评价
目前还没有评价